Union Budget 2026 boosts India’s biopharma ambitions: USAIC Washington, Feb 2 (SocialNews.XYZ) The annual Union Budget sends a clear policy signal on biopharma and healthcare innovation, the USA India Chambers of Commerce (USAIC) said, citing new investments, expansion of clinical trial infrastructure, and steps toward global regulatory alignment. The government’s early focus on biopharma, including the Biopharma Shakti initiative and the plan to create 1,000 clinical trial sites nationwide, reflected a decisive push to move India up the global value chain in biopharma and healthcare innovation, USAIC president Karun Rishi told IANS.

Union Budget 2026 boosts India’s biopharma ambitions: USAIC #UnionBudget #Indias #USAIC #socialnewsxyz